ESR1 and breast cancer: Expression of NRIF3 specifically and rapidly (within 5 h) leads to caspase-2-dependent apoptosis in a wide variety of breast cancer cell lines (Estrogen Receptor positive or negative) but not other cell types [15], [16], [17].